pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 1
CLD-101
Anaplastic Astrocytoma
$CLDICalidi Biotherapeutics, Inc.
0 catalysts
CLENPIQ
CLENPIQ (SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID)
FERRING PHARMS INC
0 catalysts
Preclinical
CLG-001
Mitochondrial Diseases
Cellergy Therapeutics Ltd
0 catalysts
CLINDAMYCIN AND BENZOYL PEROXIDE
CLINDAMYCIN AND BENZOYL PEROXIDE (CLINDAMYCIN AND BENZOYL PEROXIDE)
GLENMARK SPECLT
← prev
page 70 of 231
next →
131
Pain89
Neurology1
0 catalysts
CLINDAMYCIN PALMITATE HYDROCHLORIDE (PEDIATRIC)
CLINDAMYCIN PALMITATE HYDROCHLORIDE (PEDIATRIC) (CLINDAMYCIN PALMITATE HYDROCHLORIDE (PEDIATRIC))
Aurobindo Pharma Ltd
0 catalysts
CLINDAMYCIN PHOAPHATE TOPICAL SOLUTION USP, 1%
CLINDAMYCIN PHOAPHATE TOPICAL SOLUTION USP, 1% (CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION USP, 1%)
ENCUBE ETHICALS
0 catalysts
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE (CLINDAMYCIN AND BENZOYL PEROXIDE GEL)
SUN PHARMA CANADA
0 catalysts
CLINIMIX
CLINIMIX (LEUCINE, PHENYLALANINE, LYSINE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, SERINE, TYROSINE, DEXTROSE)
BAXTER HLTHCARE
0 catalysts
CLINIMIX E
CLINIMIX E (LEUCINE, PHENYLALANINE, LYSINE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, SERINE, TYROSINE, DIBASIC POTASSIUM PHOSPHATE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, DEXTROSE)
BAXTER HLTHCARE
0 catalysts
CLINISOL
CLINISOL (LYSINE, LEUCINE, PHENYLALANINE, VALINE, HISTIDINE, ISOLEUCINE, METHIONINE, THREONINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID, TYROSINE)
BAXTER HLTHCARE
0 catalysts
CLINOLIPID
CLINOLIPID (OLIVE OIL AND SOYBEAN OIL)
BAXTER HLTHCARE CORP
0 catalysts
Phase 2
CLIO-8221
Solid Tumor
Callio Therapeutics Inc
0 catalysts
Phase 1
CLN-049
Refractory Acute Myeloid Leukemia
$CGEMCullinan Therapeutics, Inc.
0 catalysts
Phase 1
CLN-978
Systemic Lupus Erythematosus
$CGEMCullinan Therapeutics, Inc.
0 catalysts
CLOBETASOL PROPIONATE CREAM USP, 0.05% CLOBETASOL PROPIONATE CREAM USP, 0.05%
CLOBETASOL PROPIONATE CREAM USP, 0.05% CLOBETASOL PROPIONATE CREAM USP, 0.05% (CLOBETASOL PROPIONATE CREAM USP, 0.05%)
ENCUBE
0 catalysts
CLOPIDOGREL
CLOPIDOGREL (CLOPIDOGREL)
HETERO LABS LTD V
0 catalysts
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE (CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE)
TARO
0 catalysts
CLOTRIMAZOLE TOPICAL SOLUTION USP, 1%
CLOTRIMAZOLE TOPICAL SOLUTION USP, 1% (CLOTRIMAZOLE TOPICAL SOLUTION USP, 1%)
TP ANDA HOLDINGS
0 catalysts
Phase 2
CLR-121125
Triple-Negative Breast Cancer (TNBC)
$CLRBCellectar Biosciences, Inc.
0 catalysts
Preclinical
CLRN1
Usher Syndrome
Akouos Inc
0 catalysts
Preclinical
CLS-014
Pancreatic Cancer
CLS Therapeutics
0 catalysts
Phase 1
CLY-124
Sickle Cell Disease
Cellarity Inc
0 catalysts
Preclinical
CM-109
Gastric Cancer
Excelmab Inc
0 catalysts
Preclinical
CM-110
Small-Cell Lung Cancer
Excelmab Inc
0 catalysts
Phase 2
CM-4612
Attention Deficit Hyperactivity Disorder (ADHD)
Curemark LLC
0 catalysts
Phase 3
CM-AT
LUMINENZ-AT
Autism Spectrum Disorder (ASD)
Curemark LLC
0 catalysts
Preclinical
CMN-008
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Benecyte Inc
0 catalysts
Phase 2
CMND-100
Alcohol Use Disorder (AUD)
$CMNDClearmind Medicine Inc.
0 catalysts
Phase 1
CMS-121
Alzheimer's Disease
Virogenics Inc
0 catalysts
Preclinical
CMTS-1
Type 2 Diabetes
Celdara Medical LLC
0 catalysts